The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Repeat transcatheter aortic valve replacement and implications for transcatheter heart valve performance: insights from bench testing
Janarthanan Sathananthan1; Rob Fraser2; Uri Landes3; Courtney Rich2; Stephanie Sellers3; Jonathan Leipsic3; Philipp Blanke3; Georg Lutter4; Derk Frank5; Thomas Puehler6; David A Wood3; Lars Søndergaard7; John G Webb3;
1. Centre for Heart Valve Innovation, St Paul's Hospital, University of British Columbia, Vancouver, Canada; Centre for Cardiovascular Innovation, St Paul's and Vancouver General Hospital, Vancouver, Canada, Canada 2. ViVitro Labs Inc, Victoria, Canada 3. Centre for Heart Valve Innovation, St Paul’s Hospital, University of British Columbia, Vancouver, Canada; Centre for Cardiovascular Innovation, St Paul’s and Vancouver General Hospital, Vancouver, Canada 4. Department of Experimental Cardiac Surgery and Heart Valve Replacement, University Hospital Schleswig-Holstein, Campus Kiel, Germany.; DZHK (German Centre for Cardiovascular Research). Partner site Hamburg/Kiel/Lübeck, Germany. 5. DZHK (German Centre for Cardiovascular Research). Partner site Hamburg/Kiel/Lübeck, Germany; Department of Internal Medicine III, Cardiology and Angiology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. 6. Department of Experimental Cardiac Surgery and Heart Valve Replacement, University Hospital Schleswig-Holstein, Campus Kiel, Germany. 7. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
Background. THV implantation within failed surgical valves is well established. However the implications of THV implantation within failed THVs is poorly understood.
Aims. This study assessed the impact of different transcatheter heart valve (THV) designs and implant positioning strategies on hydrodynamic performance after redo transcatheter aortic valve implantation (TAVI).
Methods. THVs of varying design (Sapien 3, Evolut Pro, Acurate neo, Allegra, and Portico) and sizes were implanted inside Sapien XT and Evolut R THVs. Hydrodynamic function as per International Standard Organization (ISO) specifications was evaluated using a pulse duplicator and multimodality imaging was performed.
Results. The majority of tested THV-in-THV combinations resulted in stable anchoring of the new implant. However some combinations resulted in unstable anchoring with the potential for dislodgement or embolization. Hydrodynamic function was favourable for all tested THV designs implanted in the intra-annular Sapien XT THV. Sapien 3 implantation within an Evolut THV with supra-annular leaflets must be appropriately sized to ensure adequate anchoring. Avoidance of an intra-annular deployment mitigated leaflet overhang of the Evolut leaflets and optimized hydrodynamic performance.
Conclusion. This study demonstrates that most THV designs and implantation strategies can result in favourable hydrodynamic performance following redo-TAVI. Whether the leaflets of a failed THV are intra- or supra-annular may have important implications for the positioning of a redo-THV implant. Certain THV designs or implantation positions may be more desirable when performing redo-TAVI.